Newest Businesses in New Jersey

Browse newly-funded private companies headquartered in New Jersey. Sorted by filing date, with the most recent on top.

About New Jersey

New Jersey's Form D filings cluster in the North Jersey corridor (Newark, Jersey City, Hoboken — NYC-metro overflow), the pharma belt (Morristown, Princeton-adjacent — home to major pharma HQs including Merck, Bristol-Myers Squibb, Johnson & Johnson), and Princeton/Central Jersey (biotech). The pharma-industry concentration produces biotech and specialty-pharma filings. Jersey City and Hoboken host fintech and SaaS filings driven by NYC-metro overflow. Round sizes span the full range. Delaware incorporation dominates; New Jersey LLCs appear for real-estate and pharma-adjacent vehicles.

In 2026, New Jersey accounts for 100 catalogued filings totaling $730M, running at roughly 20.8 filings per week over the last 30 days.

Total raised
$730M
Median offering
$4.2M
Active cities
10
Last 30 days
89

Top cities

Featured New Jersey companies in 2026

$100M

Bergamot Music Fund I LP

PRINCETON, NJ · Services · Filed Apr 17, 2026

Bergamot Music Fund I LP is a Services company based in PRINCETON, NJ. The company is a Limited Partnership, incorporated in Delaware, with…

$100M

DOMINIONXIOM INC

ATLANTIC CITY, NJ · Services · Filed Apr 10, 2026

DOMINIONXIOM INC is a Services company based in ATLANTIC CITY, NJ. The company is a Limited Liability Company, incorporated in New Jersey, w…

$100M

LEDGETHXIS INC

GALLOWAY, NJ · Services · Filed Apr 10, 2026

LEDGETHXIS INC is a Services company based in GALLOWAY, NJ. The company is a Limited Liability Company, incorporated in New Jersey, with its…

About private capital in New Jersey

New Jersey has relatively high state taxes but an extraordinary pharma and specialty-chemicals industry concentration. The state's pharma belt produces biotech and therapeutics filings with strategic investor participation from the major pharma companies headquartered locally. NYC-metro spillover drives North Jersey fintech, SaaS, and consumer-platform filings. Princeton University's research ecosystem contributes to biotech and AI filings. Real-estate vehicles target NJ multifamily and industrial/logistics assets (the state hosts major Amazon, FedEx, and industrial-REIT holdings).

New Jersey funding trends

Recent New Jersey Form D filings show several patterns. First, pharma-belt biotech filings dominate the state's dollar-volume rankings. Second, North Jersey fintech and SaaS filings reflect NYC-metro spillover. Third, industrial and logistics real-estate vehicles target NJ's last-mile-logistics ecosystem. Fourth, specialty-chemicals and advanced-manufacturing filings reflect the state's industrial base. Fifth, data-center and real-estate-infrastructure vehicles appear. New Jersey ranks in the top filing states.